Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease

Autor: Mark R. Bowling, Marc A. Judson, Michael B. Fessler, Anagha Malur, Christopher J. Wingard, Barbara P. Barna, Mary Jane Thomassen, Larry Dobbs, Kathryn M. Verbanac, Matthew McPeek
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Pulmonary and Respiratory Medicine
Sarcoidosis
Clinical Biochemistry
Granulomatous Disease
Chronic

Models
Biological

Proinflammatory cytokine
03 medical and health sciences
0302 clinical medicine
Chronic granulomatous disease
microRNA
Macrophages
Alveolar

medicine
Animals
Humans
Receptor
Molecular Biology
Original Research
ATP Binding Cassette Transporter
Subfamily G
Member 1

medicine.diagnostic_test
biology
Chemistry
Nanotubes
Carbon

Membrane Transport Proteins
Cell Biology
medicine.disease
Lipids
Mice
Inbred C57BL

Disease Models
Animal

MicroRNAs
030104 developmental biology
Bronchoalveolar lavage
030228 respiratory system
ABCG1
ABCA1
Immunology
biology.protein
Alveolar macrophage
Cancer research
lipids (amino acids
peptides
and proteins)

Bronchoalveolar Lavage Fluid
ATP Binding Cassette Transporter 1
Popis: We established a murine model of multiwall carbon nanotube (MWCNT)-induced chronic granulomatous disease, which resembles human sarcoidosis pathology. At 60 days after oropharyngeal MWCNT instillation, bronchoalveolar lavage (BAL) cells from wild-type mice exhibit an M1 phenotype with elevated proinflammatory cytokines and reduced peroxisome proliferator-activated receptor γ (PPARγ)-characteristics also present in human sarcoidosis. Based upon MWCNT-associated PPARγ deficiency, we hypothesized that the PPARγ target gene, ATP-binding cassette (ABC) G1, a lipid transporter with antiinflammatory properties, might also be repressed. Results after MWCNT instillation indicated significantly repressed ABCG1, but, surprisingly, lipid transporter ABCA1 was also repressed, suggesting a possible second pathway. Exploration of potential regulators revealed that microRNA (miR)-33, a lipid transporter regulator, was strikingly elevated (13.9 fold) in BAL cells from MWCNT-instilled mice but not sham control mice. Elevated miR-33 was also detected in murine granulomatous lung tissue. In vitro studies confirmed that lentivirus-miR-33 overexpression repressed both ABCA1 and ABCG1 (but not PPARγ) in cultured murine alveolar macrophages. BAL cells of patients with sarcoidosis also displayed elevated miR-33 together with reduced ABCA1 and ABCG1 messenger RNA and protein compared with healthy control subjects. Moreover, miR-33 was elevated within sarcoidosis granulomatous tissue. The findings suggest that alveolar macrophage miR-33 is up-regulated by proinflammatory cytokines and may perpetuate chronic inflammatory granulomatous disease by repressing antiinflammatory functions of ABCA1 and ABCG1 lipid transporters. The results also suggest two possible pathways for transporter dysregulation in granulomatous disease-one associated with intrinsic PPARγ status and the other with miR-33 up-regulation triggered by environmental challenges, such as MWCNT.
Databáze: OpenAIRE